Cargando…
Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
INTRODUCTION: Gemcitabine is a well‐known radiosensitizer. Herein, we tested the efficacy and toxicity of preoperative concurrent infusional gemcitabine and radiotherapy in locally advanced rectal cancer. PATIENTS AND METHODS: This was a phase II, single‐arm trial. Eligible patients had a diagnosis...
Autores principales: | Bazarbashi, Shouki, Elshenawy, Mahmoud A., Badran, Ahmed, Aljubran, Ali, Alzahrani, Ahmed, Almanea, Hadeel, Alsuhaibani, Abdullah, Alashwah, Ahmed, Neimatallah, Mohamed, Abduljabbar, Alaa, Ashari, Luai, Alhomoud, Samar, Ghebeh, Hazem, Elhassan, Tusneem, Alsanea, Nasser, Mohiuddin, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119355/ https://www.ncbi.nlm.nih.gov/pubmed/35146939 http://dx.doi.org/10.1002/cam4.4590 |
Ejemplares similares
-
Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies
por: Alsanea, Nasser, et al.
Publicado: (2015) -
Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II Trial
por: Bazarbashi, Shouki, et al.
Publicado: (2023) -
The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-Line Chemotherapy
por: Bazarbashi, Shouki, et al.
Publicado: (2019) -
Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy
por: Bazarbashi, Shouki, et al.
Publicado: (2022) -
Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab Population
por: Badran, Ahmed, et al.
Publicado: (2020)